Rhythm Pharmaceuticals Inc.

31/07/2024 | Press release | Distributed by Public on 31/07/2024 13:29

Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.